Topic List : Health Policy
Bereavement in pregnancy affects child
The scholars said that their study contributes to the research documenting a causal link between fetal stress exposure and mental health later in life.
Reducing tapeworm infection in kids
Tapeworm infection from eating contaminated pork can damage the brain, causing learning impairments and possibly enforcing cycles of poverty. A Stanford study is the first to look at infection rates within schools and propose solutions targeting children.
Tobacco products sold on Facebook
Several Facebook policies bar tobacco sales and promotion on the platform, but Stanford researchers found brands and vendors marketing their products through unpaid content.
Physicians discuss gun violence
Gun violence is a public-health problem that physicians may be able to help alleviate by conducting research and educating patients about gun safety, said experts at a recent teach-in on campus.
Ethics review needed for AI use in health care
In a perspective piece, Stanford researchers discuss the ethical implications of using machine-learning tools in making health care decisions for patients.
Medicare’s blame game
A Stanford researcher and his colleague got access to data showing the inner workings of an influential committee advising Medicare. They found that bias among its members has different effects from what critics claim.
More premature births after recent deployment
Giving birth soon after military deployment is linked to greater risk of premature delivery, a Stanford study of U.S. servicewomen found, but deployment history itself does not raise prematurity risk.
A patient’s bucket list helps physicians
A Stanford study has has found that a majority of people make bucket lists and suggests they can be useful in doctor-patient discussions about care plans.
VA bests Medicare in end-of-life cancer care
Medicare is more likely to provide excessive end-of-life care for cancer patients than Veterans Affairs, according to a study led by Stanford Medicine and VA researchers.
Drug for disorder sparks ethical concerns
Medical experts at Stanford and their colleagues at several other universities have raised ethical questions about the way a treatment for spinal muscular atrophy is being used.